Aethlon Medical (NASDAQ:AEMD) Stock Crosses Above 200 Day Moving Average – Time to Sell?

Shares of Aethlon Medical, Inc. (NASDAQ:AEMD) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.42 and traded as high as $0.60. Aethlon Medical shares last traded at $0.57, with a volume of 1,309,468 shares trading hands.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on AEMD. HC Wainwright reaffirmed a “buy” rating and set a $7.00 target price on shares of Aethlon Medical in a report on Friday, November 15th. StockNews.com initiated coverage on shares of Aethlon Medical in a research note on Thursday. They set a “sell” rating for the company.

Aethlon Medical Price Performance

The stock has a market cap of $7.95 million, a price-to-earnings ratio of -0.20 and a beta of 1.79. The firm has a fifty day moving average of $0.41 and a 200 day moving average of $0.42.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.